Transcranial magnetic stimulation (TMS) is a noninvasive, FDA-cleared brain stimulation treatment for adults with major depressive disorder who haven’t responded adequately to antidepressants. It delivers focused magnetic pulses to specific brain regions involved in mood regulation, requires no anesthesia, and is typically completed over a four to six week daily treatment course. TMS depression therapy is generally well-tolerated, carries a low serious-risk profile, and is most commonly recommended for treatment-resistant cases.
Key Takeaways
TMS depression therapy is an FDA-cleared, noninvasive treatment that uses targeted magnetic pulses to modulate brain circuits involved in mood, most often recommended after at least one antidepressant has failed.
| Point | Details |
|---|---|
| What TMS is | Noninvasive magnetic brain stimulation, FDA-cleared since 2008, for adults with treatment-resistant major depressive disorder. |
| Time commitment | Daily sessions five days a week for four to six weeks; many patients notice improvement within two to four weeks. |
| Effectiveness range | Meta-analyses report a range of response and remission rates that vary widely across protocols and patient history, reflecting real-world variation. |
| Insurance realities | Most payers require documented failed antidepressant trials and prior authorization; out-of-pocket cost without coverage typically runs $6,000–$12,000 for a full course. |
| Next step | Bergencountytherapist offers depression evaluations and therapy coordination in Paramus, NJ, in-person and online. |
Table of Contents
- What is TMS depression therapy and how does it work?
- TMS protocols: rTMS, dTMS, and theta-burst compared
- What to expect before, during, and after treatment
- Does TMS therapy actually work? What the evidence says
- Side effects, risks, and who should not use TMS
- What does TMS therapy cost in the United States?
- How to find a qualified TMS clinic and what to ask
- TMS works best as part of a broader treatment plan
- Bergencountytherapist supports your full depression care plan
- Sources
- FAQ
What is TMS depression therapy and how does it work?
The mechanism is straightforward once you picture it. A coil placed against the scalp generates brief electromagnetic pulses that pass through the skull and induce small electric currents in the underlying cortex. Those currents stimulate neurons in the dorsolateral prefrontal cortex (DLPFC), the region most consistently underactive in major depressive disorder.
Why the DLPFC? It sits at the intersection of emotional regulation and executive function. When its activity is chronically suppressed, mood, motivation, and cognitive flexibility all suffer. TMS targets it directly rather than flooding the whole brain with a systemic drug.
That calibration step matters because it keeps the treatment targeted and consistent across sessions. The broader process is called neuromodulation: repeated stimulation gradually shifts cortical excitability, normalizing the dysfunctional circuits that sustain depression rather than just masking symptoms.

TMS protocols: rTMS, dTMS, and theta-burst compared
Three main protocol families are in clinical use, and they differ in coil design, stimulation depth, session length, and FDA clearance status.
- High-frequency rTMS (left DLPFC): The original cleared approach. Pulses delivered at 10 Hz to the left prefrontal cortex. Standard sessions run 20–40 minutes. This is the most widely studied protocol.
- Low-frequency rTMS (right DLPFC): Uses 1 Hz stimulation on the right side to inhibit overactive circuits. Less common but used when high-frequency left-sided treatment is not tolerated.
- Deep TMS (dTMS) with H-coil: The H-coil design stimulates broader and deeper frontal regions than a standard figure-8 coil, reaching more lateral and bilateral prefrontal tissue. BrainsWay is the primary manufacturer of FDA-cleared H-coil systems.
- Theta-burst stimulation (TBS): Delivers bursts of high-frequency pulses in a compressed pattern. Intermittent TBS (iTBS) to the left DLPFC can complete a session in about three minutes, making it the fastest standard protocol currently cleared.
NeuroStar is the most widely deployed figure-8 coil system for standard rTMS in the United States; BrainsWay’s H-coil system covers the dTMS category. Both carry FDA clearance for major depressive disorder.
What to expect before, during, and after treatment
A standard acute course runs daily sessions five days a week for four to six weeks, consistent with CMS protocol guidance. Here is what each phase actually looks like.
Before your first session: A psychiatrist conducts a full evaluation covering medication history, seizure history, and any implanted devices. Motor threshold testing happens at the first session. You sit in a reclined chair, no sedation required.
During a session: The technician positions the coil against your scalp. Once stimulation begins, you’ll feel a rhythmic tapping sensation and hear a loud clicking sound from the coil contracting with each pulse. Clinics routinely provide earplugs or allow headphones. You stay awake and alert the entire time. Sessions with standard rTMS run 20–40 minutes; iTBS sessions can finish in under ten minutes.
After a session: No recovery time. Most people drive themselves home and return to work immediately. Some notice mild scalp tenderness or a headache for an hour or two after early sessions; this usually fades within the first week. Tracking your mood daily during treatment helps you and your provider spot when improvement begins. A practical tool for that is monitoring your mental health systematically so changes don’t go unnoticed.
Many patients report symptom improvement within two to four weeks, though full benefit typically follows completion of the acute course. After the acute phase, some clinics offer maintenance sessions (monthly or as needed) or a re-induction course if symptoms return.
Does TMS therapy actually work? What the evidence says
TMS has consistent evidence of benefit for treatment-resistant major depressive disorder and has carried FDA clearance since 2008, as outlined in resources about mental health regulatory context and neurostimulation therapies. The honest answer on effectiveness is that it works for a meaningful portion of patients, but not everyone.
Response and remission rates vary significantly across meta-analyses and clinical reviews, reflecting real variation across protocols, patient populations, and study designs.
That wide range reflects something important: outcomes depend heavily on how many prior antidepressants have failed, patient age, comorbid conditions, and which protocol is used. A patient who has failed two medications responds differently than one who has failed six. Review literature covering rTMS, dTMS, and TBS consistently shows that newer protocols like TBS produce comparable results to standard rTMS in less chair time.
Compared to medication, TMS avoids systemic side effects like weight gain, sexual dysfunction, and sedation. Compared to electroconvulsive therapy (ECT), TMS carries a far lower risk profile and requires no general anesthesia, though ECT still shows higher remission rates in the most severe cases. Response durability is meaningful: a substantial portion of responders maintain benefit at six to twelve months, with re-induction available for relapse.
The practical timeline: some patients notice mood shifts by week two. Most who respond see clear improvement by the end of the full course. Stopping early because “nothing is happening yet” at week one is one of the most common reasons for suboptimal outcomes.
Side effects, risks, and who should not use TMS
Side effects are mostly mild and front-loaded in the first week.
Common, usually transient:
- Scalp discomfort or pain at the coil site
- Headache, typically resolving within an hour
- Jaw or facial muscle twitching during stimulation
- Hearing sensitivity from coil noise (mitigated by ear protection)
Contraindications your clinic will screen for:
- Implanted ferromagnetic hardware near the head (cochlear implants, certain aneurysm clips, deep brain stimulators)
- Active intracranial devices
- Uncontrolled seizure disorder or a history of epilepsy
Rare but serious: Seizure risk in non-epileptic patients is very low, under 0.01% per session, but clinics must be equipped to manage one if it occurs. This is why TMS is delivered in medical or supervised clinical settings, not retail wellness centers.
Pro Tip: Before your first appointment, compile a complete list of all medications (including supplements), any history of head injury or neurological events, and the exact model of any implanted device. Bring the device card if you have one. This information directly determines whether you’re a candidate and how the motor threshold is set.
What does TMS therapy cost in the United States?
Cost varies significantly by region, clinic type, and insurance status. A full acute course typically runs between $6,000 and $12,000 out of pocket without insurance coverage, though per-session rates and total session counts affect the final figure.
Insurance coverage is real but requires work. CMS and most major payers require documentation of at least one adequate antidepressant trial failure, a face-to-face psychiatric evaluation, and prior authorization before approving TMS. Some payers require two or more failed medication trials. The prior-auth process can take two to four weeks, so starting it early matters.
Practical steps: ask the clinic’s billing coordinator exactly which payers they’re in-network with, what documentation they’ll submit on your behalf, and what the appeal process looks like if the first authorization is denied. Many clinics have dedicated insurance staff who handle this regularly and know which payer-specific hurdles to anticipate.
Medicare covers TMS for major depressive disorder under specific LCD criteria. Medicaid coverage varies by state. Private insurers increasingly cover it, but policy language differs enough that a direct call to your insurer before committing to a clinic is worth the time.
How to find a qualified TMS clinic and what to ask
Not all TMS clinics are equivalent. The device is FDA-cleared, but the quality of psychiatric oversight, staff training, and follow-up care varies considerably.
What to verify before committing:
- A board-certified psychiatrist oversees the program and reviews your case
- The clinic offers motor threshold testing at the first session (not a one-size-fits-all setting)
- Staff are trained on the specific device being used (NeuroStar, BrainsWay, or another cleared system)
- The facility has emergency protocols in place for rare adverse events
- The clinic coordinates with your existing psychiatrist or therapist rather than operating in isolation
Questions worth asking directly:
- What is your response rate in patients with my medication history?
- Do you offer TBS or only standard rTMS, and how do you decide which protocol to use?
- What does your maintenance plan look like after the acute course?
- How do you handle a partial response — do you adjust parameters mid-course?
- What is the realistic out-of-pocket cost if my insurance denies coverage?
Published outcome data from the clinic is a green flag. A clinic that can share its own response and remission numbers, even informally, is one that tracks results. Coordination with your current depression therapy provider is not optional — it’s what makes TMS part of a treatment plan rather than a standalone gamble.
TMS works best as part of a broader treatment plan
The framing that TMS “replaces” medication or therapy misses how most psychiatrists actually use it. TMS is a tool for resetting a brain that hasn’t responded to first-line treatments, not a standalone cure. The patients who do best tend to be those who continue psychotherapy during and after the TMS course, maintain whatever medication management is appropriate, and have realistic expectations about the timeline.
When a psychiatrist recommends TMS, it’s usually after two or more antidepressant trials have produced inadequate results. At that point, the conversation shifts from “which medication next” to “what else can we do.” TMS fits that gap well precisely because it works through a different mechanism entirely, targeting the circuit directly rather than adjusting neurotransmitter availability system-wide.
What gets underestimated is the role of the therapeutic relationship during TMS. Patients are showing up every day for weeks. That consistency, combined with active psychotherapy, creates a window for real change. The neuromodulation may lower the threshold for the brain to respond to therapy, though the comparison between therapy and medication approaches remains an active clinical conversation. Shared decision-making matters here: the best outcomes come when the patient, psychiatrist, and therapist are aligned on goals and monitoring progress together.
Bergencountytherapist supports your full depression care plan
If you’re weighing TMS as an option, the next step isn’t just finding a TMS clinic. It’s making sure you have the right clinical support around it. Bergencountytherapist, led by Dr. Stephen Oreski, offers comprehensive depression evaluations and therapy in Paramus, NJ, with both in-person and online appointments available. The practice provides individual psychotherapy, medication management coordination, and can help you think through whether TMS referral makes sense for your situation. If you’re already in a TMS course, ongoing therapy during treatment is one of the clearest ways to improve outcomes. Schedule an evaluation to discuss your depression treatment options and get a coordinated plan in place.
Sources
- LCD – Transcranial Magnetic Stimulation (TMS) in the Treatment of Adults with Major Depressive Disorder (L34522)
- PMC article on TMS mechanisms and parameters
- Repetitive Transcranial Magnetic Stimulation – StatPearls – NCBI Bookshelf
- PRSN Lab document on TMS safety and seizure rates
- What Happens During a TMS Session: A Step-by-Step Guide – BalancePW
FAQ
How does TMS help with depression?
TMS delivers magnetic pulses to the dorsolateral prefrontal cortex, a brain region consistently underactive in major depressive disorder, gradually normalizing the neural circuits that regulate mood. Repeated sessions over four to six weeks produce cumulative neuromodulatory effects that reduce depressive symptoms.
Does TMS treatment really work?
Yes, for a meaningful portion of patients. It is most effective for treatment-resistant depression after antidepressants have failed.
What does TMS therapy feel like?
You’ll feel a rhythmic tapping on your scalp and hear a loud clicking sound from the coil during each pulse. Most patients find it tolerable; clinics provide earplugs or headphones. Mild scalp discomfort or a brief headache after early sessions is common and usually fades within the first week.
How quickly does TMS work?
Many patients notice symptom improvement within two to four weeks of starting treatment, though full benefit typically follows completion of the entire acute course. Stopping early before that window closes is one of the most common reasons outcomes fall short.



